Open access · CC-BY
via OpenAlex
Progress of immunotherapy of anti-α-synuclein in Parkinson’s disease
Zhipeng Wang, Ge Gao, Chunli Duan, Hui Yang
Biomedicine & Pharmacotherapy · 2019 · ▲ 60 citations
Abstract
Many neurodegenerative diseases are characterized by progressive loss of neurons and abnormal protein accumulation, including amyloid (A)β and tau in Alzheimer's disease and Lewy bodies and α-synuclein (α-syn) in Parkinson's disease (PD). Recent evidence suggests that adaptive immunity plays an important role in PD, and that anti-α-syn antibodies can be used as therapy in neurodegenerative diseases; monoclonal antibodies were shown to inhibit α-syn propagation and aggregation in PD models and patients. In this review, we summarize the different pathological states of α-syn, including gene mutations, truncation, phosphorylation, and the high molecular weight form, and describe the specific antibodies that recognize the α-syn monomer or oligomer, some of which have been tested in clinic trials. We also discuss future research directions and potential targets in PD therapy.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.biopha.2019.108843
- Canonical
- link ↗
- Fetched
- 2026-10-28 MST
Cite this
APA
Wang, Z., Gao, G., Duan, C., & Yang, H. (2019). Progress of immunotherapy of anti-α-synuclein in Parkinson’s disease. <em>Biomedicine & Pharmacotherapy</em>. https://doi.org/10.1016/j.biopha.2019.108843
Vancouver
Wang Z, Gao G, Duan C, Yang H. Progress of immunotherapy of anti-α-synuclein in Parkinson’s disease. Biomedicine & Pharmacotherapy. 2019. doi:10.1016/j.biopha.2019.108843.
BibTeX
@article{zhipeng2019Progre,
title = {Progress of immunotherapy of anti-α-synuclein in Parkinson’s disease},
author = {Zhipeng Wang and Ge Gao and Chunli Duan and Hui Yang},
journal = {Biomedicine & Pharmacotherapy},
year = {2019},
doi = {10.1016/j.biopha.2019.108843},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Alzheimer s Research & Therapy 2014
Open access · CC-BY
Alpha-synuclein biology in Lewy body diseases
Biomolecules 2015
Open access · CC-BY
Interaction between Neuromelanin and Alpha-Synuclein in Parkinson’s Disease
Human Molecular Genetics 2014
Open access · OA
Early Parkinson's disease symptoms in -synuclein transgenic monkeys
Parkinson s Disease 2016
Open access · CC-BY
Alpha-Synuclein in Parkinson’s Disease: From Pathogenetic Dysfunction to Potential Clinical Application
Oxidative Medicine and Cellular Longevity 2012
Open access · CC-BY
Antioxidant Therapies for Alzheimer's Disease
Biomolecules 2014
Open access · CC-BY